Upload File

oncologypro.esmo.org...tao 1671." 2016 design phase i retrospective retrospective i...

  • Home
  • Documents
  • oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
30

Upload: others

Post on 21-Feb-2020

2 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 2: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 3: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 4: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 5: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 6: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 7: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 8: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 9: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 10: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 11: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 12: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 13: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 14: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 15: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 16: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 17: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 18: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 19: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 20: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 21: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 22: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 23: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 24: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 25: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 26: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 27: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 28: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 29: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 30: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy

Hepatic Glycogenolysis

Extra hepatic and large intra hepatic bile ducts

Radiologic manifestation of hepatic pseudolesions and ......small hepatic lesions, particularly small hepatic tumors, such as HCC and metastatic tumors. CT during hepatic arteriography

NON-INVASIVE ASSESSMENT METHODS OF HEPATIC FIBROSIS … fibrosis in chronic hepatic disease... · NON-INVASIVE ASSESSMENT METHODS OF HEPATIC FIBROSIS IN CHRONIC HEPATIC DISEASE OF

Hepatic Abscess

Hepatic Tumors; Hydatid Cyst; Hepatic Trauma

Hepatic / GI

Hepatic Encephalopaty

Hepatic Infections

 · Web viewTitle Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases Authorship

Hepatic Failure

The Retrospective Games - Meetupfiles.meetup.com/1479426/The Retrospective Games.pdfThe Retrospective Games Setup – Pre-selected Retrospective activities (eg. innovative, time constraint)

  · Web viewVersion 1.1 Intrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma and Hepatocellular Carcinoma 1st revision, published October 2017

Cancer Hepatic

Diagnostic accuracy of staging laparoscopy for detecting … · 2017-04-10 · Keywords Perihilar cholangiocarcinoma Staging laparoscopy Yield Diagnostic accuracy Resectability Perihilar

Hepatic Trauma

SABR: Central Lung Early Stage NSCLC...peripheral vs. 54% perihilar/central – 4 of 6 deaths from toxicity were in patients with perihilar/central tumors • “No-Fly Zone”- within

Hepatic Cancer

Hepatic Physiology

Celiac trunk and hepatic artery variants: A retrospective ... · ent types of celiac trunk variants demonstrated in our study as seen in Fig. 11. 4. Discussion Celiac trunk and hepatic

Modern work-up and extended resection in perihilar

Hepatic Encephalopathy

Hepatic failure.pdf

HEPATIC DISORDERS

Hepatic Decompensations. Agenda Hepatic decompensations Hepatic encephalopathy –Treatment/precipitating factors SBP –Differentiate from secondary peritonitis

Resection of Perihilar Cholangiocarcinoma

Liver, gallbladder, bile ducts, pancreas...topography • C23.9 = gallbladder • C24.0 = extrahepatic bile ducts • Proximal/perihilar part: hepatic duct • Cystic duct • C24.8/C24.9

Hepatic Cirrhosis

Hepatic doppler

cholangiocarcinoma, gallbladder cancer, common bile duct, cystic duct, intrahepatic, perihilar

Cc Hepatic

Intrahepatic Cholangiocarcinoma, Perihilar

HEPATIC TUMORS

Hepatic Encephalopathy Update: Prophylactic Therapy … · Hepatic Encephalopathy Update: Prophylactic Therapy to Prevent Hepatic Encephalopathy Hepatic encephalopathy (HE) is a complication

Caloric Restriction Reverses Hepatic Insulin … Restriction Reverses Hepatic Insulin Resistance and ... Hepatic Insulin Resistance and Steatosis in Rats ... impaired hepatic insulin